I estimate the intrinsic worth of Moderna, the COVID 19 vaccine producer at 340 billion USD.
The main reason for my opinion for the high probable future Moderna market capitalisation is the current coronavirus situation in China, which can be likened to a full blown crisis.
With so many infections reported by authorities in China, some medical doctors think and forecast the COVID 19 coronavirus could form a new COVID19 coronavirus mutation strain, which could be much more dangerous and more infectious than the existing COVID19 variants.
There are media reports that the COVID 19 coronavirus vaccines produced by Chinsese pharmaceutical biotechnology firms are not as effective as Moderna or Pfizer BioNTech's COVID19 vaccine shots.
Which naturally leads to the supposition that the demand for Moderna's COVID19 vaccine could increase exponentially in the midterm.
No comments:
Post a Comment